Bracco’s “The Beauty of Imaging” The multimedia installation explaining the importance of diagnostic imaging is now on display at STEP, to relate the future of radiology and precision medicine

Bracco joins the UN Global Compact The UN Global Compact is a call to companies everywhere to align their operations and strategies with ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption.

Efficacy and Safety of Gadopiclenol The results of the multicenter, multinational PICTURE clinical trial demonstrate that 0.05 mmol/kg gadopiclenol provides similar morphologic information about CNS lesions and greater contrast enhancement compared with 0.1 mmol/kg gadobutrol.

Whistleblowing Procedures and guidelines for Whistleblowing

The Impact of Seeing the Full Picture Bracco’s standpoint on sustainability - and environmental sustainability in particular - is that it is essential to look at the full picture.

ECR 2023 Official page for Bracco Imaging's participation in the European Congress of Radiology (ECR) 2023. Learn more about our medical imaging solutions and products for cardiology and radiography.

Bracco’s VUEWAY™ (gadopiclenol) injection now in hospitals Preeminent Hospitals and Medical Practices Nationwide Lead in Patient Care with First Use of Bracco’s VUEWAY™ (gadopiclenol) solution for injection for MRI.

Bracco announces the birth of Bracco Japan Ltd Bracco will acquire all shares of Bracco-Eisai held by Eisai and change its name from Bracco-Eisai to Bracco Japan, Ltd.  as of April 1, 2023.

AI and Radiology: mutual game changers At ECR 2023 in Vienna, we discussed what means to be Gamechangers in radiology and how this aligns with the Bracco motto “Unlocking the Invisible”.

Bracco è Marchio Storico di Interesse Nazionale L’azienda, nata nel 1927 e oggi leader globale nella diagnostica per immagini, entra a far parte dell’esclusivo gruppo di imprese storiche che rappresentano la punta di diamante del Made in Italy.